WHERE AI & DATA MINING MEETS CANCER IMMUNOTHERAPY Trademark

Trademark Overview

On Wednesday, November 3, 2021, a trademark application was filed for WHERE AI & DATA MINING MEETS CANCER IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the WHERE AI & DATA MINING MEETS CANCER IMMUNOTHERAPY trademark a serial number of 97106294. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 19, 2023. This trademark is owned by Kiromic Biopharma, Inc.. The WHERE AI & DATA MINING MEETS CANCER IMMUNOTHERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
where ai & data mining meets cancer immunotherapy

General Information

Serial Number97106294
Word MarkWHERE AI & DATA MINING MEETS CANCER IMMUNOTHERAPY
Filing DateWednesday, November 3, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Pseudo MarkWHERE AI AND DATA MINING MEETS CANCER IMMUNOTHERAPY
Goods and ServicesPharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKiromic Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77054
Party NameKiromic Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77054

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 19, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 12, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 18, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 6, 2021NEW APPLICATION ENTERED

Related Keywords

cancer immunotherapy meets mining data where research development pharmaceutical diseases related fields biotechnology pharmaceuticals treatment